Advertisement
Screener

MANNKIND CORP (MNKD) Basic Shares Outstanding (Weighted Average)

2.8 / 5 stars · 68/120 Roast Me

MANNKIND CORP Basic Shares Outstanding (Weighted Average)

MANNKIND CORP (MNKD) reported Basic Shares Outstanding (Weighted Average) of 309.19 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05

  • MANNKIND CORP weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 309.19M shares, a 1.39% increase year-over-year.
  • MANNKIND CORP weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 308.27M shares, a 1.58% increase year-over-year.
  • MANNKIND CORP weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 307.28M shares, a 10.05% increase year-over-year.
  • MANNKIND CORP weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 306.81M shares, a 11.57% increase year-over-year.
  • MANNKIND CORP weighted average number of shares outstanding, basic for fiscal 2025 was 305.64M shares, a 11.38% increase from fiscal 2024.
  • MANNKIND CORP weighted average number of shares outstanding, basic for fiscal 2024 was 274.42M shares, a 2.77% increase from fiscal 2023.
  • MANNKIND CORP weighted average number of shares outstanding, basic for fiscal 2023 was 267.01M shares, a 3.86% increase from fiscal 2022.
  • MANNKIND CORP weighted average number of shares outstanding, basic for fiscal 2022 was 257.09M shares, a 3.15% increase from fiscal 2021.
Period endWeighted Average Number of Shares Outstanding, Basic 3 monthWeighted Average Number of Shares Outstanding, Basic 3 month as first filedWeighted Average Number of Shares Outstanding, Basic 6 monthWeighted Average Number of Shares Outstanding, Basic 9 monthWeighted Average Number of Shares Outstanding, Basic 9 month as first filedWeighted Average Number of Shares Outstanding, Basic 12 month
2026-06-30309.19M shares
10-Q · filed 2026-08-05
308.73M shares
10-Q · filed 2026-08-05
308.25M shares
derived: average of 3 quarters · filed 2026-08-05
307.89M shares
derived: average of 4 quarters · filed 2026-08-05
2026-03-31308.27M shares
10-Q · filed 2026-05-06
307.77M shares
derived: average of 2 quarters · filed 2026-05-06
307.45M shares
derived: average of 3 quarters · filed 2026-05-06
306.83M shares
derived: average of 4 quarters · filed 2026-08-05
2025-12-31307.28M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
307.04M shares
derived: average of 2 quarters · filed 2026-02-26
306.35M shares
derived: average of 3 quarters · filed 2026-08-05
305.64M shares
10-K · filed 2026-02-26
2025-09-30306.81M shares
10-Q · filed 2025-11-05
305.88M shares
derived: average of 2 quarters · filed 2026-08-05
305.09M shares
10-Q · filed 2025-11-05
298.62M shares
derived: average of 4 quarters · filed 2026-08-05
2025-06-30304.95M shares
10-Q · filed 2026-08-05
304.22M shares
10-Q · filed 2026-08-05
295.89M shares
derived: average of 3 quarters · filed 2026-08-05
290.67M shares
derived: average of 4 quarters · filed 2026-08-05
2025-03-31303.48M shares
10-Q · filed 2026-05-06
291.35M shares
derived: average of 2 quarters · filed 2026-05-06
285.90M shares
derived: average of 3 quarters · filed 2026-05-06
282.69M shares
derived: average of 4 quarters · filed 2026-05-06
2024-12-31279.23M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
277.11M shares
derived: average of 2 quarters · filed 2026-02-26
275.76M shares
derived: average of 3 quarters · filed 2026-02-26
274.42M shares
10-K · filed 2026-02-26
2024-09-30275.00M shares
10-Q · filed 2025-11-05
274.03M shares
derived: average of 2 quarters · filed 2025-11-05
272.81M shares
10-Q · filed 2025-11-05
272.02M shares
derived: average of 4 quarters · filed 2026-02-26
2024-06-30273.06M shares
10-Q · filed 2025-08-06
271.71M shares
10-Q · filed 2025-08-06
271.03M shares
derived: average of 3 quarters · filed 2026-02-26
270.46M shares
derived: average of 4 quarters · filed 2026-02-26
2024-03-31270.36M shares
10-Q · filed 2025-05-08
270.02M shares
derived: average of 2 quarters · filed 2026-02-26
269.59M shares
derived: average of 3 quarters · filed 2026-02-26
268.60M shares
derived: average of 4 quarters · filed 2026-02-26
2023-12-31269.68M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26
269.20M shares
derived: average of 2 quarters · filed 2026-02-26
268.01M shares
derived: average of 3 quarters · filed 2026-02-26
267.01M shares
10-K · filed 2026-02-26
2023-09-30268.73M shares
10-Q · filed 2024-11-07
267.18M shares
derived: average of 2 quarters · filed 2024-11-07
266.13M shares
10-Q · filed 2024-11-07
265.44M shares
derived: average of 4 quarters · filed 2025-02-26
2023-06-30265.63M shares
10-Q · filed 2024-08-07
264.80M shares
10-Q · filed 2024-08-07
264.35M shares
derived: average of 3 quarters · filed 2025-02-26
263.09M shares
derived: average of 4 quarters · filed 2025-02-26
2023-03-31263.97M shares
10-Q · filed 2024-05-08
263.71M shares
derived: average of 2 quarters · filed 2025-02-26
262.24M shares
derived: average of 3 quarters · filed 2025-02-26
260.09M shares
derived: average of 4 quarters · filed 2025-02-26
2022-12-31263.45M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26
261.37M shares
derived: average of 2 quarters · filed 2025-02-26
258.80M shares
derived: average of 3 quarters · filed 2025-02-26
257.09M shares
10-K · filed 2025-02-26
2022-09-30259.30M shares
10-Q · filed 2023-11-07
256.47M shares
derived: average of 2 quarters · filed 2023-11-07
254.97M shares
10-Q · filed 2023-11-07
253.98M shares
derived: average of 4 quarters · filed 2024-02-27
2022-06-30253.64M shares
10-Q · filed 2023-08-07
252.78M shares
10-Q · filed 2023-08-07
252.21M shares
derived: average of 3 quarters · filed 2024-02-27
251.64M shares
derived: average of 4 quarters · filed 2024-02-27
2022-03-31251.89M shares
10-Q · filed 2023-05-09
251.50M shares
derived: average of 2 quarters · filed 2024-02-27
250.97M shares
derived: average of 3 quarters · filed 2024-02-27
250.55M shares
derived: average of 4 quarters · filed 2024-02-27
2021-12-31251.10M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27
250.51M shares
derived: average of 2 quarters · filed 2024-02-27
250.10M shares
derived: average of 3 quarters · filed 2024-02-27
249.24M shares
10-K · filed 2024-02-27
2021-09-30249.91M shares
10-Q · filed 2022-11-08
249.60M shares
derived: average of 2 quarters · filed 2022-11-08
248.62M shares
10-Q · filed 2022-11-08
2021-06-30249.29M shares
10-Q · filed 2022-08-09
247.97M shares
10-Q · filed 2022-08-09
2020-12-31222.59M shares
10-K · filed 2023-02-23
2018-12-31161.40M shares
10-K · filed 2019-02-26
157.50M shares
derived: average of 2 quarters · filed 2019-02-26
151.68M shares
derived: average of 3 quarters · filed 2019-02-26
144.14M shares
10-K · filed 2019-02-26
2018-09-30153.60M shares
10-K · filed 2019-02-26
146.83M shares
derived: average of 2 quarters · filed 2019-02-26
138.19M shares
derived: average of 3 quarters · filed 2019-02-26
132.75M shares
derived: average of 4 quarters · filed 2019-02-26
2018-06-30140.05M shares
10-K · filed 2019-02-26
130.48M shares
derived: average of 2 quarters · filed 2019-02-26
125.81M shares
derived: average of 3 quarters · filed 2019-02-26
120.53M shares
derived: average of 4 quarters · filed 2019-02-26
2018-03-31120.91M shares
10-K · filed 2019-02-26
118.68M shares
derived: average of 2 quarters · filed 2019-02-26
114.02M shares
derived: average of 3 quarters · filed 2019-02-26
110.48M shares
derived: average of 4 quarters · filed 2019-02-26
2017-12-31116.45M shares
10-K · filed 2019-02-26
110.58M shares
derived: average of 2 quarters · filed 2019-02-26
107.01M shares
derived: average of 3 quarters · filed 2019-02-26
104.25M shares
10-K · filed 2019-02-26
2017-09-30104.70M shares
10-K · filed 2019-02-26
102.28M shares
derived: average of 2 quarters · filed 2019-02-26
100.14M shares
10-Q · filed 2017-11-07
99.00M shares
derived: average of 4 quarters · filed 2019-02-26
2017-06-3099.86M shares
10-K · filed 2019-02-26
97.80M shares
derived: average of 2 quarters · filed 2019-02-26
97.09M shares
derived: average of 3 quarters · filed 2019-02-26
96.73M shares
derived: average of 4 quarters · filed 2019-02-26
2017-03-3195.74M shares
10-K · filed 2019-02-26
95.71M shares
derived: average of 2 quarters · filed 2019-02-26
95.68M shares
derived: average of 3 quarters · filed 2019-02-26
94.53M shares
derived: average of 4 quarters · filed 2019-02-26
2016-12-3195.68M shares
10-K · filed 2018-02-27
95.65M shares
derived: average of 2 quarters · filed 2018-02-27
94.12M shares
derived: average of 3 quarters · filed 2018-02-27
92.05M shares
10-K · filed 2019-02-26
2016-09-3095.63M shares
10-K · filed 2018-02-27
478.14M shares
10-Q · filed 2016-11-09
93.34M shares
derived: average of 2 quarters · filed 2018-02-27
90.84M shares
10-Q · filed 2017-11-07
454.19M shares
10-Q · filed 2016-11-09
-151.95M shares
derived: average of 4 quarters · filed 2018-02-27
2016-06-3091.06M shares
10-K · filed 2018-02-27
88.42M shares
derived: average of 2 quarters · filed 2018-02-27
-234.48M shares
derived: average of 3 quarters · filed 2018-02-27
-74.56M shares
derived: average of 4 quarters · filed 2018-02-27
2016-03-3185.77M shares
10-K · filed 2018-02-27
-397.25M shares
derived: average of 2 quarters · filed 2018-02-27
-129.77M shares
derived: average of 3 quarters · filed 2018-02-27
2015-12-31-880.27M shares
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
-237.54M shares
derived: average of 2 quarters · filed 2018-02-27
81.23M shares
10-K · filed 2018-02-27
2015-09-30405.20M shares
10-Q · filed 2016-11-09
401.73M shares
10-Q · filed 2016-11-09
2014-12-3177.05M shares
10-K · filed 2017-03-16

Similar stocks

Stock NameCountryMarket CapPE Ratio
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Savara Inc (SVRA)United States$1.044B-9.10
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Seaport Therapeutics, Inc. (SPTX)United States$1.131B
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19